Results 101 to 110 of about 9,558 (171)

Информация о новом противотуберкулезном препарате Таваник®

open access: yesКачественная клиническая практика, 2018
Левофлоксацин (Таваник) - активный левовращающий изомер офлоксацина (L-офлоксацин). Левофлоксацин обладает более низкой, чем офлоксацин, токсичностью в отношении клеточных элементов легочной ткани.

doaj  

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium. [PDF]

open access: yesBull World Health Organ, 2017
Smit GS   +12 more
europepmc   +1 more source

AN INTEGRATED SYSTEM FOR PREDICTION OF ADVERSE OUTCOME DURING ANTI-TUBERCULOSIS TREATMENT

open access: yesФундаментальная и клиническая медицина, 2016
Тo develop a comprehensive method for evaluating the risk of an adverse outcome during anti-tuberculosis (anti-TB) treatment. Materials and Methods: We recruited 10,398 adult patients with either primary pulmonary TB or TB relapse.
Tatiana V. Pianzova   +2 more
doaj  

ТУБЕРКУЛЕЗ У ДЕТЕЙ НА УКРАИНЕ

open access: yesТуберкулез и болезни лёгких, 2014

doaj   +1 more source

Patient-led active tuberculosis case-finding in the Democratic Republic of the Congo. [PDF]

open access: yesBull World Health Organ, 2018
André E   +13 more
europepmc   +1 more source

[Coexistance of primary hyperparathyroidism and sarcoidosis in a hypercalcemic patient]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Danilova LI   +6 more
europepmc   +1 more source

Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons. [PDF]

open access: yesBull World Health Organ, 2015
Maggard KR   +11 more
europepmc   +1 more source

[A unique case of severe ACTH-dependent Cushing's syndrome due to ectopic corticotropin production by medullary thyroid carcinoma]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Timofeeva NI   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy